KI-Beratung Beta

Produktbild: Smart Approaches for Cancer Diagnosis, Therapy, and Its Associated Challenges
Vorbesteller Neu

Smart Approaches for Cancer Diagnosis, Therapy, and Its Associated Challenges

Fr. 238.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Smart Approaches for Cancer Diagnosis, Therapy, and its Associated Challenges presents a comprehensive exploration of cutting-edge technologies transforming cancer care. This edited volume bridges foundational science with clinical relevance, offering insights into theranostics, nanomedicine, and molecular...

Beschreibung

Smart Approaches for Cancer Diagnosis, Therapy, and its Associated Challenges presents a comprehensive exploration of cutting-edge technologies transforming cancer care. This edited volume bridges foundational science with clinical relevance, offering insights into theranostics, nanomedicine, and molecular therapeutics. The book delves into advanced diagnostic tools such as biosensors and theranostic nanoparticles, and therapeutic innovations including peptide-drug conjugates, epigenetic modulation, and nucleic acid-based treatments. It addresses key challenges in glioblastoma, pediatric brain tumors, and drug-resistant cancers, while highlighting translational strategies that integrate diagnostics and therapy. Academics benefit from a multidisciplinary reference that supports research, fosters innovation, and enhances understanding of emerging cancer therapies. It equips researchers with the latest developments to advance precision medicine and improve patient outcomes.

Portrait

Professor Paul A. Millner is a leading figure in bionanotechnology at the University of Leeds, currently serving as a Visiting Professor in the School of Biomedical Sciences. He earned his BSc in Biochemistry and PhD in Plant Sciences from Leeds, followed by postdoctoral research at Purdue University and Imperial College London. Initially focused on plant cell signaling, his research transitioned to biotechnology, emphasizing biosensors, biocatalysis and cancer theranostics.

Professor Millner's work centers on integrating biomolecules like enzymes and synthetic receptors (e.g., Affimers) with non-biological surfaces to develop functional devices for diagnostics and environmental applications. His group has pioneered reagentless electrochemical immunosensors and explored nanoparticle-based systems for targeted drug delivery and imaging. Notably, he coordinated EU-funded projects such as ELISHA and SANTS, leading to the establishment of ELISHA Systems Ltd. He has published more than 150 research articles and numerous books and book chapters.

Dr. Arindam Pramanik is an Assistant Professor at the Amity University Noida, and serves as a Visiting Research Fellow at the University of Leeds. He earned his PhD in Life Science and Biotechnology from Jadavpur University, focusing on targeted drug delivery using polymeric and metal-based nanoparticles. His postdoctoral research includes prestigious fellowships from India's Department of Science and Technology (DST) and Department of Biotechnology (DBT). As a part of Newton fellowship from royal society at University of Leeds, he contributed to cancer therapeutics, notably developing Affimer-conjugated cubosomes for targeted delivery to colon and breast cancer cells. He has been recognized internationally, earning him the Joe Gray Travel Award by Oregon State University, USA. Dr. Pramanik's research interests encompass cancer biomarkers, gene therapy, and nanostructured drug delivery systems, including liposomal and hydrogel-based platforms. He is leading multiple research projects and has published numerous book/chapters in reputed journals.

Dr. Ajay Kumar is currently working as an assistant professor at Amity Institute of Biotechnology, Amity University, Noida, India. Dr. Kumar recently completed his tenure as a visiting scientist from Agriculture Research Organization, Volcani Center, Israel. He has published more than 200 research, review articles, and book chapters in international and national journals. He serves as an associate editor for Frontiers in Microbiology, BMC Microbiology and as guest editor for various journals such as Plants, Microorganisms, and Sustainability. Dr. Kumar has also edited more than 40 books with the leading publishers such as Elsevier, Springer, and Wiley. Dr. Kumar’s research experience is in the field of plant–microbe interactions, postharvest management, cyanobacterial biology, and so on

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.01.2027

Herausgeber Paul A. Millner + weitere
Verlag Elsevier

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.01.2027

Herausgeber
Verlag Elsevier
Seitenzahl

330

Maße (L/B)

27.6/21.6 cm

Gewicht

450 g

Sprache

Englisch

ISBN

978-0-443-50994-0

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Smart Approaches for Cancer Diagnosis, Therapy, and Its Associated Challenges
  • 1. Cancer Theranostic: A Conceptual Framework and Overview of Current Approaches
    2. Advances in Sensors and Biosensors for Cancer Detection
    3. Nanoparticle-Based Cancer Diagnosis: Innovations in Imaging and Biomarker Detection
    4. Metallic Nanoparticles for Theranostic Applications
    5. Cancer Metabolomics: Biomarker Discovery and Clinical Translation
    6. Nanotechnology in Targeted Drug Delivery for Cancer Therapy
    7. Innovative Strategies in Therapeutic Management of Glioblastoma
    8. Stromal Regulation of Therapy Responses in Breast Cancers
    9. Advances of Peptide-Drug Conjugates for Management of Metastatic Cancers
    10. Epigenetic Approaches in Cancer Therapy
    11. Nucleic Acid-Based Approaches for Cancer Therapeutics
    12. Harnessing the Power of Extracellular Vehicles in Cancer Therapy
    13. Advancements in Immunotherapy, Vaccines and CAR-T Therapy
    14. Challenges for Drug Discovery in Paediatric Brain Tumors
    15. Overcoming Challenges in Drug Resistant Cancer Therapeutics
    16. Bridging the Translational Divide: Current Gaps and Future Directions in Cancer Theranostics